Evidence map›Paper›PMID 33028359›Full record

ArticleJournal of experimental & clinical cancer research : CR2020

Calreticulin promotes EMT in pancreatic cancer via mediating Ca

Weiwei Sheng, Guosen Wang, Jingtong Tang, Xiaoyang Shi, Rongxian Cao, Jian Sun, Yi Heng Lin, Chao Jia, Chuanping Chen, Jianping Zhou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. NCancer gene therapy · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Calreticulin as a marker and therapeutic target for cancer.Clinical and experimental medicine · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Weiwei ShengDepartment of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, Liaoning, China.
Guosen WangDepartment of General Surgery, The First Affliated Hospital, Nanchang University, Nanchang, 330006, Jiangxi, China.
Jingtong TangDepartment of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, Liaoning, China.
Xiaoyang ShiDepartment of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, Liaoning, China.
Rongxian CaoDepartment of General Surgery, The People's Hospital of Liaoning province, Shenyang, 110034, Liaoning, China.
Jian SunDepartment of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, Liaoning, China.
Yi Heng LinDepartment of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, Liaoning, China.
Chao JiaDepartment of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, Liaoning, China.
Chuanping ChenDepartment of Clinical Laboratory, The Sixth Peoples' hospital of Shenyang, Shenyang, 110003, Liaoning, China.
Jianping ZhouDepartment of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, Liaoning, China.
Ming DongDepartment of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, Liaoning, China. dongming@cmu.edu.cn.ORCID http://orcid.org/0000-0003-2685-1420
First Hospital of China Medical University · CNLiaoning Provincial People's Hospital · CNNanchang University · CNThe Sixth People's Hospital of Shenyang · CN

Funding

Chinese National Science Foundation 81672835Chinese National Science Foundation for youth scholar 81401941Scientific innovation plan from Young and middle-aged talents of Shenyang City RC200357Scientific research project of Education Department of Liaoning Province L2020
6 · The paper itself

Abstract

backgroundOur previous study showed that calreticulin (CRT) promoted EGF-induced epithelial-mesenchymal transition (EMT) in pancreatic cancer (PC) via Integrin/EGFR-ERK/MAPK signaling. We next investigated the novel signal pathway and molecular mechanism involving the oncogenic role of CRT in PC.

methodsWe investigated the potential role and mechanism of CRT in regulating intracellular free Ca

resultsThapsigargin (TG) induced acute ERS via increasing intracellular free Ca

conclusionsCRT promotes EMT in PC via mediating intracellular free Ca

Indexed as

Endoplasmic Reticulum StressEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticAnimalsApoptosisBiomarkers, TumorCalciumCalreticulinCell ProliferationEndoribonucleasesFemaleHumansMaleMiceMice, Inbred BALB CMice, NudeBiomarkers, TumorCalciumCalreticulinCALR protein, humanEndoribonucleasesERN1 protein, humanProtein Serine-Threonine KinasesX-Box Binding Protein 1XBP1 protein, humanCalreticulinEndoplasmic reticulum stressEpithelial mesenchymal transitionIntracellular free Ca2 +IRE1αPancreatic cancer

Identifiers

PMID33028359
PMCPMC7542892
OpenAlexW3091923113

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.